Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years
Published inOsteoporosis international, vol. 26, no. 12, p. 2763-2771
Publication date2015
Affiliation entities
Research groups
Citation (ISO format)
FERRARI, Serge Livio et al. Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years. In: Osteoporosis international, 2015, vol. 26, n° 12, p. 2763–2771. doi: 10.1007/s00198-015-3179-x
Main files (1)
Article (Published version)
Identifiers
- PID : unige:79131
- DOI : 10.1007/s00198-015-3179-x
Additional URL for this publicationhttp://link.springer.com/10.1007/s00198-015-3179-x
Journal ISSN0937-941X
